Comparative Efficacy and Safety of Bruton Tyrosine Kinase and Spleen Tyrosine Kinase Inhibitors in Immune Thrombocytopenia: A Network Meta-Analysis of Clinical Trials.
- DOI
- 10.1002/jha2.70433
- Published
- 2026 Oct
- Container
- EJHaem
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/jha2.70433,
title = {Comparative Efficacy and Safety of Bruton Tyrosine Kinase and Spleen Tyrosine Kinase Inhibitors in Immune Thrombocytopenia: A Network Meta-Analysis of Clinical Trials.},
author = {Abulehia A and Alshareef RB and Khateeb S and Ghanem U and Abadi A and Zatar N and Bael P and Sweity R and Ghanem H and Ayesh H},
year = {2026},
journal = {EJHaem},
doi = {10.1002/jha2.70433},
url = {https://doi.org/10.1002/jha2.70433}
}RIS
TY - JOUR TI - Comparative Efficacy and Safety of Bruton Tyrosine Kinase and Spleen Tyrosine Kinase Inhibitors in Immune Thrombocytopenia: A Network Meta-Analysis of Clinical Trials. AU - Abulehia A AU - Alshareef RB AU - Khateeb S AU - Ghanem U AU - Abadi A AU - Zatar N AU - Bael P AU - Sweity R AU - Ghanem H AU - Ayesh H PY - 2026 JO - EJHaem DO - 10.1002/jha2.70433 UR - https://doi.org/10.1002/jha2.70433 ER -
APA
A, A., RB, A., S, K., U, G., A, A., N, Z., P, B., R, S., H, G., & H, A. (2026). Comparative Efficacy and Safety of Bruton Tyrosine Kinase and Spleen Tyrosine Kinase Inhibitors in Immune Thrombocytopenia: A Network Meta-Analysis of Clinical Trials.. EJHaem. https://doi.org/10.1002/jha2.70433
Source records
- pubmed · retrieved 2026-11-11T01:13:15.559Z